These independent CME/CE activities are supported by an educational grant from Novartis Pharmaceuticals Corporation.



       Rheumatology Mastery in
   Ankylosing
   Spondylitis
  1. Course List
Chair
faculty image
John D. Reveille, MD
  • Division Director/Professor
  • Department of Rheumatology
  • UT Health Science Center at Houston
  • Houston, Texas
  • Rheumatology Mastery in Ankylosing Spondylitis is designed to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in ankylosing spondylitis. The curriculum includes case studies at the point of care and MedPage Today meeting coverage that will report on cutting-edge news as it breaks from the British Society for Rheumatology (BSR) 2017 and European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology 2017 and poster presentations offering audio/video of presenters, downloadable PDF copies of posters, full transcripts of presentations, noted expert summations of key takeaways, and clinical applications.
  • Describe the importance of early diagnosis of ankylosing spondylitis, and recent advances in our understanding of mechanisms that may serve as targets of therapy.
  • Evaluate criteria that have been developed to assess treatment response in ankylosing spondylitis, delineate how these criteria can be used to risk-stratify patients in clinical practice, and consider therapeutic treatment options that improve patient outcomes.
  • Target Audience

    This program is designed for rheumatologists, primary care physicians, and other clinicians involved in the screening and treatment of patients with ankylosing spondylitis.

     

    Activity Goal

    The goal of this program is to provide new information based on breaking medical news, new data presented at medical meetings, and case studies on current and emerging management strategies on the most up-to-date evidence-based medicine and clinical trial results in ankylosing spondylitis.